Liraglutide for patients with non-alcoholic steatohepatitis - ScienceDirect

The Lancet

Volume 387, Issue 10036, 11–17 June 2016, Page 2378

The Lancet

https://doi.org/10.1016/S0140-6736(16)30733-4 Get rights and content

References (2)

M Armstrong et al.
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Lancet
(2016)
M Armstrong et al.
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
BMJ Open
(2013)

Cited by (2)

Increased body fat percentage in patients with hepatitis B and C virus infection
2018, PLoS ONE
GLP-1-analogs in the treatment of steatohepatitis
2016, Diabetologe

© 2016 Elsevier Ltd. All rights reserved.